{"schema_version":"secwatch.filing_event.v1","accession":"0000021076-24-000027","form_type":"8-K","ticker":"CLX","cik":"0000021076","company_name":"CLOROX CO /DE/","filed_at":"2024-08-01T23:59:59+00:00","discovered_at":"2026-05-14T18:03:15.408520+00:00","generated_at":"2026-05-31T14:04:17.736136+00:00","sec_items":["2.02","7.01","9.01"],"event_type":"earnings","sentiment":"positive","materiality_score":0.85,"calibrated_materiality_score":0.85,"confidence":"high","headline":"Clorox Q4 net sales -6% to $1.9B; adjusted EPS +9% to $1.82; divests VMS business","bullets":["Q4 GAAP diluted EPS $1.73 (+22% YoY); adjusted EPS $1.82 (+9%) vs $1.67.","Gross margin 46.5% (+380 bps) on lower costs; organic sales -3%.","Announces sale of Better Health VMS business to Piping Rock Health Products; no deal value disclosed.","FY24 free cash flow $483M vs $930M; net cash from ops $695M.","FY25 outlook: expects return to volume growth consistent with long-term goals."],"urls":{"canonical":"https://secwatch.observer/filing/0000021076-24-000027","json":"https://secwatch.observer/filing/0000021076-24-000027.json","markdown":"https://secwatch.observer/filing/0000021076-24-000027.md","text":"https://secwatch.observer/filing/0000021076-24-000027.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/21076/000002107624000027/0000021076-24-000027-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/21076/000002107624000027/clx-20240801.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-31T14:04:17.736136+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}